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Background: The identification of eligible controlled trials for systematic reviews of complementary and alternative
medicine (CAM) interventions can be difficult. To increase access to these difficult to locate trials, the Cochrane
Collaboration Complementary Medicine Field (CAM Field) has established a specialized register of citations of CAM
controlled trials. The objective of this study is to describe the sources and characteristics of citations included in the
CAM Field specialized register.
Methods: Between 2006 and 2011, regular searches for citations of CAM trials in MEDLINE and the Cochrane
Central Register of Controlled Trials (CENTRAL) were supplemented with contributions of controlled trial citations
from international collaborators. The specialized register was ‘frozen’ for analysis in 2011, and frequencies were
calculated for publication date, language, journal, presence in MEDLINE, type of intervention, and type of medical
condition.
Results: The CAM Field specialized register increased in size from under 5,000 controlled trial citations in 2006 to
44,840 citations in 2011. Most citations (60%) were from 2000 or later, and the majority (71%) were reported in
English; the next most common language was Chinese (23%). The journals with the greatest number of citations
were CAM journals published in Chinese and non-CAM nutrition journals published in English. More than one-third
of register citations (36%) were not indexed in MEDLINE. The most common CAM intervention type in the register
was non-vitamin, non-mineral dietary supplements (e.g., glucosamine, fish oil) (34%), followed by Chinese herbal
medicines (e.g., Astragalus membranaceus, Schisandra chinensis) (27%).
Conclusions: The availability of the CAM Field specialized register presents both opportunities and challenges for
CAM systematic reviewers. While the register provides access to thousands of difficult to locate trial citations, many
of these trials are of low quality and may overestimate treatment effects. When including these trials in systematic
reviews, adequate analysis of their risk of bias is of utmost importance.
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Complete identification of eligible controlled trials is an
essential step in conducting a systematic review, and
finding and collecting citations of controlled trials have
been aims of the Cochrane Collaboration from its incep-
tion 20 years ago. As part of this mission, the Collabo-
ration developed the Cochrane Central Register of
Controlled Trials (CENTRAL), a searchable database of
citations of controlled trials [1]. The Collaboration has
agreements with the publishers of MEDLINE and
EMBASE, ensuring that all citations of controlled trials
from those databases are republished in CENTRAL.
Cochrane entities (e.g., Cochrane Review Groups) also
regularly submit citations of controlled trials to CEN-
TRAL, ensuring that CENTRAL contains trial citations
from multiple sources, including not only MEDLINE
and EMBASE, but also regional and subject-specific
databases, as well as trial citations not included in data-
bases. Because of the Collaboration’s extensive efforts at
identification of trials from a range of sources, CEN-
TRAL is considered to be the most comprehensive
source of citations of controlled trials for inclusion in
systematic reviews [1].
The complete identification of eligible controlled trials
can be particularly challenging for systematic reviews of
CAM interventions. The disadvantage of relying exclu-
sively upon sources such as MEDLINE for trial identifica-
tion is illustrated by research conducted by Egger and
colleagues. Egger and colleagues [2] analyzed the charac-
teristics of 1,635 controlled trials included in a group of
n = 159 systematic reviews, including both conventional
and CAM-related reviews. They found that in CAM-
related systematic reviews, the proportion of non-
MEDLINE-indexed trials (41%) was approximately twice
that proportion seen in conventional medicine systematic
reviews (21%). If the systematic review authors had
searched only MEDLINE for trials, they would have
missed many trials, possibly including some important tri-
als, and the proportion missing from CAM reviews would
have been double the proportion missing from conven-
tional medicine reviews. Earlier research using various
‘gold standard sets’ of known trials for specific CAM inter-
ventions found that the percentage of known trials in-
cluded in MEDLINE was 58% for acupuncture trials [3],
31% for ginkgo trials [4], and 17% for homeopathy trials
[4]. Ensuring that CENTRAL contains both MEDLINE
and non-MEDLINE citations of CAM-related controlled
trials is therefore important for the unbiased conduct of
Cochrane systematic reviews of CAM interventions.
The CAM Field maintains a specialized register of
citations of controlled trials of CAM interventions,
which is a ‘subregister’ of CENTRAL. In 1998, a biblio-
metric analysis of the CAM Field specialized register
described it as containing 3,774 controlled trials [5]. In2006, the CAM Field began an active program to im-
prove the scope and size of the CAM Field specialized
register. CAM Field staff and international partners in
this endeavor performed searches of bibliographic
databases and paper journals, and CAM Field staff
performed extensive quality checks and de-duplication
of all identified citations. As a result of these efforts, the
CAM Field register contained a total of 43,310 CAM
Field specialized register citations as of Issue 1, 2012, of
The Cochrane Library. CAM Field specialized register
citations can be retrieved from the Cochrane Central
Register of Controlled Trials (CENTRAL) database of
The Cochrane Library by searching for the tag ‘SR-
COMPMED’ in all text. The objective of this study is to
describe the sources and characteristics of the trial cita-
tions included in the CAM Field specialized register.
Methods
In 2011 we drew up a detailed protocol (see Additional
file 1) that described the eligibility criteria for including
citations and the methods we had used to build the
register. The protocol also pre-specified the methods we
planned to use in examining the characteristics of the
citations in the register. A summary of these methods,
as well as the details of contributions of trial citations by
international collaborators, is presented below.
Eligibility criteria
All citations in the CAM Field specialized register are
required to meet the following two inclusion criteria: (1)
they must be reports of controlled trials, and (2) they
must be CAM-related.
We considered controlled trials to be studies meeting
the inclusion criteria for CENTRAL that were formu-
lated and agreed upon in November 1992 and are pub-
lished in Chapter 6.3 of the Cochrane Handbook [6]. We
considered trials to be CAM-related if they described in-
terventions that are outside the practices and theories of
disease and healing that are intrinsic to the conventional
Western medical model [7]. To retrieve citations of
CAM trials from MEDLINE and CENTRAL, we relied
upon the CAM on PubMed search strategy, which was
jointly developed by the US National Library of Medi-
cine and the US National Institutes of Health, National
Center for Complementary and Alternative Medicine,
and introduced in PubMed in 2001 [8,9]. In cases where
some uses of the intervention are accepted within
conventional Western medicine and others are not (e.g.,
vitamin supplementation), the CAM on PubMed search
strategy generally does not distinguish between conven-
tional and unconventional uses of an intervention.
Therefore, for classifying interventions as conventional
or CAM, we followed the same operational criteria
we had previously developed for classifying Cochrane
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of the major decisions about the scope of CAM were as
follows: we excluded vitamins and other supplements
that are administered parenterally in hospital settings,
we excluded dietary supplementation for treatment or
prevention of medically diagnosed deficiency states (e.g.,
iron supplementation for preventing or treating iron
deficiency), and we excluded vitamin supplements for
preventing or treating disease in countries where vitamin
deficiency is widespread (e.g., vitamin A for treating
measles in children in Niger). We included vitamins for
other conditions, even vitamins that are accepted for the
prevention or treatment of specific disorders (e.g., folic
acid for preventing neural tube defects). In general, we
decided that we should be over-inclusive rather than
under-inclusive with vitamin therapies, aside from the
three major exclusions detailed above, and therefore
some of the vitamin trials in the database would not be
accepted as CAM by most people. Finally, we excluded
exercise interventions with the exception of mind-body
exercise (e.g., yoga), and we excluded conventional psy-
chotherapies. A full description of the CAM Field oper-
ational definition of CAM has been published previously
(see Additional file 2) [10].
Methods for building the register of trials
We began the expansion of the CAM Field specialized
register of trials by building upon the reference manage-
ment database of nearly 5,000 CAM controlled trial cita-
tions developed during the 1990s and early 2000s by
Vickers and colleagues [5]. In 2006, we began regular
searches of MEDLINE in PubMed using the CAM on
PubMed search strategy. In 2008, an information spe-
cialist translated the CAM on PubMed search strategy
into a format for use in CENTRAL, and we replaced
searches of PubMed with regular searches of CENTRAL.
The rationale for replacing searches of PubMed with
searches of CENTRAL is that CENTRAL includes not
only controlled trial citations from MEDLINE, but also
controlled trial citations from multiple other sources.
These other citations, which may be from other data-
bases or from difficult to locate sources such as trial
proceedings, are identified by Cochrane contributors
around the world and contributed to CENTRAL. All
Cochrane groups then search CENTRAL in order to
identify relevant citations that others have contributed.
We began by searching CENTRAL from inception and
then searched newly added citations in each subsequent
issue of CENTRAL.
An important subset of CAM is traditional medicine,
defined by the World Health Organization as “the sum
total of knowledge, skills and practices based on the the-
ories, beliefs and experiences indigenous to different cul-
tures that are used to maintain health, as well as toprevent, diagnose, improve or treat physical and mental
illnesses. Traditional medicine that has been adopted by
other populations (outside its indigenous culture) is
often termed alternative or complementary medicine”
[11]. Different countries often have their own forms of
traditional medicine (e.g., traditional Chinese medicine,
traditional Korean medicine). Because we did not have
access to the traditional medicine trial reports that are
published in regional or national databases and journals,
in 2008 we began contacting Cochrane colleagues and
contributors to solicit the contributions of citations of
traditional medicine trials published in their regions.
These efforts are described below. Searches of PubMed,
and then of CENTRAL, were thus complemented
with searches of bibliographic databases and journals
conducted by several international groups who contrib-
uted citations of trial reports to the CAM Field for in-
clusion in the CAM Field register. Citations provided by
contributing organizations were not restricted by publi-
cation year. As described below, two of these contribut-
ing groups also provided PDFs of the full text
publications for all identified citations. Collaborators are
listed below in order of numbers of citations submitted
to the CAM Field for the specialized register.Traditional Chinese medicine (TCM) trials identified by
Chinese collaborators
Beginning in 2008, staff at the Center for Evidence-
Based Medicine of the Beijing University of Chinese
Medicine, under the direction of Jianping Liu, searched
both electronic databases and Chinese journals to iden-
tify citations of controlled trials of TCM interventions.
The journal titles, article titles, and abstracts (if avail-
able) of all identified citations were translated into
English, entered into a reference management database
with added topic keywords, and submitted to the CAM
Field for inclusion in the specialized register. The full
text report was also submitted to the CAM Field for
each citation in a PDF format.Trials from CAM-specific databases identified by Canadian
collaborators
In 2008, information specialists under the direction of
David Moher of the Ottawa Hospital Research Institute
undertook a project to search several specialized data-
bases for difficult to locate controlled trials of CAM
interventions, and these searches were replicated in
2010 [12]. All identified citations were imported into a
reference management database, information about the
source database and the type of CAM intervention was
included for each citation, and the database was submit-
ted to the CAM Field for inclusion in the CAM Field
specialized register.
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collaborators
In 2010, researchers at the Korea Institute of Oriental
Medicine, under the direction of Myeong Soo Lee,
searched both electronic databases and journals to iden-
tify citations of controlled trials of traditional medicine
interventions conducted in Korea and primarily pub-
lished in non-MEDLINE journals. Initial searches were
focused on identifying trials of acupuncture [13] and
ginseng, and were then expanded to include all other
CAM interventions. The journal titles, article titles, and
abstracts (if available) of all identified citations were
translated into English and entered into a reference
management database with topic keywords, and the
citations were submitted to the CAM Field. For each
citation, the full text publication was also submitted to
the CAM Field in a PDF format.
Kampo trials identified by Japanese collaborators
Kampo is the Japanese adaptation of traditional Chinese
medicine. While Kampo uses most of the interventions of
Chinese medicine, including acupuncture and moxibus-
tion, its primary focus is on the study and evaluation of
traditional herbal medicines. In 2001, the Japan Society for
Oriental Medicine undertook a project to collect con-
trolled trial evidence on Kampo interventions through
searches of both electronic databases and journals [14]. As
randomized controlled trials of Kampo interventions are
identified, structured abstracts are prepared for each trial,
and the citations and structured abstracts are published
online in English. In March 2011, one of the leaders of this
initiative, Kiichiro Tsutani of the University of Tokyo, pro-
vided permission for the CAM Field staff to incorporate
the citations associated with these Kampo trials into the
CAM Field specialized register together with links to the
online structured abstracts.
Ayurveda and other CAM-related trials identified by
Indian collaborators
The South Asian Database of Controlled Clinical Trials
(SADCCT) is an online database of citations of controlled
trials that have been conducted in countries for which the
South Asian Cochrane Network & Centre is the reference
Cochrane Centre, including Afghanistan, Bangladesh,
Bhutan, India, the Maldives, Nepal, Pakistan, and Sri
Lanka. The SADCCT was developed by searching South
Asian journals and conference proceedings for all con-
trolled trials [15]. In 2011, staff at the South Asian
Cochrane Network & Centre, under the direction of
Prathap Tharyan, identified and forwarded citations of
South Asian trials of Ayurveda, Unani, Siddha, and other
CAM interventions included in the SADCCT, and in 2012
staff at the CAM Field identified additional trial citations
from the online SADCCT.CAM trials identified by African collaborators
The African Trials Register is a database of citations of
controlled trials conducted in Africa. It has been deve-
loped at the South African Cochrane Centre by the
Cochrane Centre staff searching African journals and elec-
tronic bibliographic databases [16,17]. In 2011, citations of
CAM-related trials included in the African Trials Register
were identified by Elizabeth Pienaar, information specialist
at the South African Cochrane Centre, and a database of
citations was forwarded to the CAM Field.
Methods for examining the contents of the register of
trials
In August 2011, we suspended additions of new search
results to the CAM Field specialized register and began
an intensive program of cleaning and updating the regis-
ter in preparation for analysis, focusing on detection and
removal of any non-CAM or non-controlled trial cita-
tions, deduplication of register citations, identification of
whether each register citation was present or absent in
MEDLINE, and standardization of journal names (see
Additional file 1 for details of procedures used). Because
EMBASE is a second major database from which con-
trolled trials are automatically downloaded to CEN-
TRAL, we also wished to characterize the EMBASE
coverage of CAM Field register citations. However,
register citations do not contain EMBASE identifiers,
and we did not have the resources to comprehensively
check all citations for presence in EMBASE. We there-
fore estimated the proportion of register citations
present in EMBASE by taking a random sample of 200
register records and searching EMBASE for each citation
in the sample. We used the same random sample to esti-
mate the overlap in coverage between MEDLINE and
EMBASE, and the proportion of register citations not
present in either MEDLINE or EMBASE.
We sorted journal titles by frequency and the 100
journals associated with the greatest number of trial cita-
tions were classified as either CAM or conventional in
focus, using the classification method described in the
protocol (see Additional file 1). For each of the 25 CAM
and 25 conventional journals with the greatest number
of trial citations, we determined the language of publica-
tion and whether the journal was indexed in MEDLINE.
In addition to characterizing the journals with the
greatest number of citations, we also examined the dis-
tribution of citations across all journals in the register to
determine to what extent citations are scattered across
journals overall.
To characterize register citations by CAM interven-
tion, we chose 21 different types of CAM interventions
within five broad categories. We based the 5 broad cat-
egories and the 21 intervention types within categories
upon the CAM Field topics list for Cochrane reviews of
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of CAM interventions (e.g., the classifications of CAM
interventions used in the 2007 NHIS survey of use of
CAM in the United States [18]). We then developed
subject searches for each of the 21 types of CAM inter-
ventions by parsing the 2006 translation of the CAM on
PubMed search strategy into the CAM intervention
topic areas. We also consulted additional sources to
identify any supplementary terms and to help under-
stand and delineate between the CAM intervention topic
areas. Searches were run and tested in MEDLINE, using
each relevant term. An information specialist developed
the MEDLINE version of each search strategy, which
was then peer reviewed by an independent information
specialist using the PRESS standard [19]. Searches were
then adapted so that they could be used to search the
reference management database containing the register.
MEDLINE Medical Subject Heading (MeSH) terms and
free text terms were sought in all database fields. The
search strategies for identifying each of the 21 different
types of CAM interventions are included as an additional
file so that these strategies will be publicly available to
CAM systematic reviewers developing searches for any of
these classes of therapies (see Additional file 3).
To characterize register citations by medical condi-
tions, we used the 25 categories of medical conditions
listed in the browse list on the home page of The
Cochrane Library [20]. We developed subject searches
for each medical condition category by consulting
Cochrane reviews grouped under each of these 25
categories to ascertain relevant search terms and con-
cepts, and additional sources to identify any supple-
mentary terms. Searches were run and tested in
MEDLINE in the same manner as described above
for the CAM intervention searches, although these
searches on medical conditions were not peer
reviewed. Search strategies were then adapted so that
they could be used to search the CAM register and
augmented with additional free text synonyms for
relevant medical conditions. Both MeSH and free text
terms were sought in all reference management data-
base fields.
Results
At the time of our analysis, the CAM Field register of
trials included 44,840 citations of CAM trials, which
represented approximately 6% of the total number of all
trial citations in CENTRAL [21]. Of these 44,840 CAM
trial citations, 15,990 (36%) are not included in
MEDLINE. Among the random sample of 200 register
citations checked for EMBASE status, 63/200 (31.5%;
95% CI 25% to 38%) are not included in EMBASE.
Among these 63 citations not included in EMBASE, only
7/63 (11.1%; 95% CI 3% to 19%) are included inMEDLINE. Among the 69/200 sample citations not in-
cluded in MEDLINE, only 13/69 (18.8%; 95% CI 10% to
28%) are included in EMBASE. Overall, 56/200 (28%;
95% CI 22% to 34%) of sample citations are not included
in either MEDLINE or EMBASE.
There is a substantial increase in the numbers of trial
citations published for each 5-year time period, and the
majority of the citations are from more recent publica-
tion years (see Figure 1). This increase in the numbers
of trial citations included in the CAM Field register over
publication year time periods corresponds to a similar
increase over publication year periods seen overall in
CENTRAL [22].
The most common languages in the register after
English are Chinese (n = 10,376; 23%), German (n = 963;
2%), Korean (n = 330; 0.7%), Japanese (n = 312; 0.7%),
and Russian (n = 227; 0.5%). The representation of cita-
tions in languages other than English probably reflects
both the number of trials published in that language as
well as our methods of sourcing the trial citations for
the register. For example, the number of trials in
Chinese reflects both the fact that Chinese journals pub-
lish a large number of trials of traditional Chinese medi-
cine interventions (e.g., acupuncture, Chinese herbal
medicine) [23] and also the fact that we have collabo-
rated with our partner institution in China, since 2008,
to search Chinese journals and databases to identify
these trials. More recent collaborations have resulted in
the identification and inclusion in the register of trad-
itional medicine trial citations from other countries
(see Table 1). Searches of trials by several of these collab-
orating institutions are ongoing.
The 25 conventional journal titles and 25 CAM jour-
nal titles with the largest number of citations in the
register are listed in Tables 2 and 3, respectively. Nearly
all (24/25) of the top conventional medicine journals are
MEDLINE-indexed, while only 12/25 of the top 25
CAM journals are MEDLINE-indexed. Together, these
50 journals account for 13,731 trials (30.6% of the total)
and 8,445 of these trial citations (61.5%) are MEDLINE-
indexed. The clinical focus of the conventional journals
was concentrated in nutrition (n = 8), general and in-
ternal medicine (n = 4), and pediatrics (n = 3). The clin-
ical focus of the top 25 CAM journals was concentrated
in TCM (n = 20).
The CAM register contains citations from 4,845
journals. Citations are quite concentrated in a few
journals. One-third of the citations are found in the top
57 journals and two-thirds come from the top 420
journals. Among the 4,425 journals containing the
remaining one-third of citations, 2,749/4,425 (62%) con-
tributed only 1 or 2 citations to the register.
Of the 44,840 trial citations in the register, 93% were
classified into one or more of the CAM intervention
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Figure 1 Number of citations in the CAM Field specialized register by citation publication year. * The drop in the number of trial citations
for 2007–2011 may be partially due to incomplete indexing of trials published in this recent time period and/or may be partially due to our
having suspended additions of new search results to the CAM Field specialized register in August 2011.
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greatest concentrations were in non-vitamin, non-
mineral dietary supplements (e.g., glucosamine, fish oil);
Chinese herbal medicine (e.g., Astragalus membrana
ceus, Schisandra chinensis); diet-based therapies; vitamin
and mineral interventions; and acupuncture (Table 4).
The high representation of acupuncture and Chinese
herbal medicine trial citations in the register might be
explained by both a large number of trials being pub-
lished in these areas as well as by the methods that we
used to source the trial citations for the database (as de-
scribed above).Table 1 Source of citations in the CAM Field specialized regis
Source of citations
Contributing organization
Beijing University of Chinese Medicine
Ottawa Hospital Research Institute
Japan Society for Oriental Medicine
Korea Institute of Oriental Medicine
South Asian Cochrane Centre & Network
South African Cochrane Centre
Total citations from contributing organizations
Total citations from other sources (e.g., searches of CENTRAL)
TotalsOf the 44,840 citations in the register, 85% were classi-
fied into 1 or more of the 25 categories of medical
conditions. The greatest concentrations were in the cat-
egories of heart and circulation, anesthesia and pain,
mental health, and endocrine and metabolic conditions
(Table 5). Categories varied greatly in the proportion of
citations included on MEDLINE, and the lowest percent-
age of MEDLINE-indexed citations was among citations
not classified into any medical condition category. This
is likely a result of non-MEDLINE citations being less
likely to have abstracts or detailed keywords, and thus
being less easy to categorize through searches.ter
All citations n (% of
citations in register)
Non-MEDLINE N (% of non-
MEDLINE citations in register)
6,484 (14%) 6,183 (39%)
2,967 (7%) 2,777 (17%)
351 (1%) 293 (2%)
307 (1%) 304 (2%)
71 (<1%) 31 (<1%)
26 (<1%) 0 (0)
10,206 (23%) 9,588 (60%)
34,634 (77%) 6,402 (40%)
44,840 (100%) 15,990 (100%)
Table 2 Twenty-five conventional medicine journals with the most citations in the CAM Field specialized register
Journal name* Number of citations
(% of citations in register)
Language of full text MEDLINE-indexed
The American Journal of Clinical Nutrition 1,027 (2.3) English Yes
European Journal of Clinical Nutrition 381 (0.8) English Yes
The Journal of Nutrition 362 (0.8) English Yes
The British Journal of Nutrition 310 (0.7) English Yes
Lancet 247 (0.6) English Yes
BMJ 223 (0.5) English Yes
Pain 182 (0.4) English Yes
Journal of Consulting and Clinical Psychology 178 (0.4) English Yes
Behaviour Research and Therapy 170 (0.4) English Yes
Journal of Clinical Rehabilitative Tissue Engineering Research
(Zhong Guo Zu Zhi Gong Cheng Yan Jiu Yu Lin Chuang Kang Fu)
166 (0.4) Chinese No
Archives of Physical Medicine and Rehabilitation 164 (0.4) English Yes
Journal of the American College of Nutrition 156 (0.3) English Yes
Diabetes Care 144 (0.3) English Yes
JAMA: Journal of the American Medical Association 136 (0.3) English Yes
Atherosclerosis 132 (0.3) English Yes
Journal of Clinical Endocrinology and Metabolism 131 (0.3) English Yes
Nutrition (Burbank, Los Angeles County, Calif.) 128 (0.3) English Yes
Pediatrics 127 (0.3) English Yes
The Journal of Pediatrics 121 (0.3) English Yes
Lipids 119 (0.3) English Yes
The New England Journal of Medicine 111 (0.2) English Yes
Arzneimittel-Forschung 110 (0.2) English, German† Yes
Medicine and Science in Sports and Exercise 91 (0.2) English Yes
Journal of Pediatric Gastroenterology and Nutrition 90 (0.2) English Yes
Journal of the American Dietetic Association 88 (0.2) English Yes
Total 5,094 (11.4)
*Totals include named journals and any predecessor journals that were continued by the named journal.
†Articles are published in either German or English, and abstracts are available in both languages.
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The CAM Field specialized register is an important re-
source for both MEDLINE and non-MEDLINE citations
of CAM controlled trials. The prevalence of MEDLINE-
indexed trial citations reflects the searches conducted in
PubMed (and later in CENTRAL) for MEDLINE-
indexed citations retrieved using the CAM on PubMed
search strategy. We must therefore acknowledge the
strides made in identification of both controlled trial
and CAM citations by the US National Library of
Medicine since the CAM Field specialized register was
last examined in 1998 [5]. The large number of non-
MEDLINE citations reflects searches of CENTRAL,
which includes non-MEDLINE citations, and the efforts
of CAM Field collaborators in China, Canada, Japan,
and Korea, whose contributions to the specialized regis-
ter were of predominantly non-MEDLINE citations.Overall, less than two-thirds of register citations are
MEDLINE-indexed, and Sampson et al. concluded that
with incomplete MEDLINE indexing of a body of litera-
ture, a specialized register was of particular utility [24].
Particular strengths of the register include citations of
nutritional and supplement-related interventions, and
traditional medicine. While citations of chelation the-
rapy, nutrition and supplement-related interventions,
sensory art therapies, relaxation, and meditation are
likely to be MEDLINE-indexed (at least 80% of all these
citations are indexed in MEDLINE), citations of trad-
itional medicine interventions and homeopathy are less
likely to be MEDLINE-indexed (fewer than 50% indexed
in MEDLINE) and thus may be more difficult to locate.
Therefore, the CAM Field specialized register may be a
particularly useful resource for identifying citations of
trials to be included in systematic reviews of traditional
Table 3 Twenty-five complementary medicine journals with the most citations in the CAM Field specialized register
Journal name* Number of citations
(% of citations in register)
Language of
full text
MEDLINE-
indexed
Chinese Journal of Integrated Traditional and Western Medicine
(Zhong Guo Zhong Xi Yi Jie He Za Zhi)
1,809 (4.0) Chinese Yes
Chinese Journal of Information on Traditional Chinese Medicine
(Zhong Guo Zhong Yi Yao Xin Xi Za Zhi)
1,049 (2.3) Chinese No
Chinese Acupuncture & Moxibustion (Zhongguo zhen jiu) 1,021 (2.3) Chinese No
Shanghai Journal of Acupuncture and Moxibustion (Shang Hai Zhen Jiu Za Zhi) 557 (1.2) Chinese No
Journal of Traditional Chinese Medicine 367 (0.8) English Yes
Journal of Alternative and Complementary Medicine 357 (0.8) English Yes
Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
(Zhong Xi Yi Jie He Gan Bing Za Zhi)
356 (0.8) Chinese No
Modern Journal of Integrated Traditional Chinese and Western Medicine (Xian Dai
Zhong Xi Yi Jie He Za Zhi)
350 (0.8) Chinese No
Journal of Manipulative and Physiological Therapeutics 274 (0.6) English Yes
Chinese Traditional Patent Medicine (Zhong Cheng Yao) 231 (0.5) Chinese No
China Journal of Chinese Materia Medica (Zhong Guo Zhong Yao Za Zhi) 189 (0.4) Chinese Yes
Shanghai Journal of Traditional Chinese Medicine (Shang Hai Zhong Yi Yao Za Zhi) 186 (0.4) Chinese No
Hebei Journal of Traditional Chinese Medicine (He Bei Zhong Yi) 184 (0.4) Chinese No
Chinese Journal of Integrative Medicine 178 (0.4) English Yes
The American Journal of Chinese Medicine 169 (0.4) English Yes
Shandong Journal of Traditional Chinese Medicine (Shan Dong Zhong Yi Za Zhi) 163 (0.4) Chinese No
Complementary Therapies in Medicine 150 (0.3) English Yes
World Journal of Acupuncture-Moxibustion 147 (0.3) English No
China Journal of Traditional Chinese Medicine and Pharmacy
(Zhong Hua Zhong Yi Yao Za Zhi)
146 (0.3) Chinese No
Jiangsu Journal of Traditional Chinese Medicine (Jiang Su Zhong Yi Yao) 134 (0.3) Chinese No
Acupuncture Research (Zhen Ci Yan Jiu) 133 (0.3) Chinese Yes
Journal of Chinese Integrative Medicine (Zhong Xi Yi Jie He Xue Bao) 129 (0.3) Chinese Yes
Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 128 (0.3) English Yes
Journal of Psychosomatic Research 124 (0.3) English Yes
Journal of the Korean Acupuncture & Moxibustion Society
(Taehan Chimgu Hakhoe chi)
106 (0.2) Korean No
Total 8,637 (19.3)
*Totals include named journals and any predecessor journals that were continued by the named journal.
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CAM Field specialized register may be a useful source of
trials for systematic reviews covering CAM interventions
for medical conditions in which a lower proportion of
citations are MEDLINE-indexed (e.g., endocrine and
metabolic conditions or infectious disease).
Among the 4,845 journals containing citations in the
CAM Field register, 9% contain two-thirds of the register
citations, and 57% contain only one or two register cita-
tions each. One unanswered question is whether this
distribution of journals in the register represents the true
distribution of CAM trials across journals or whether in-
stead it is an artifact resulting from the way that theregister was developed. There is no way to definitively
answer this question because there exists no ‘gold stand-
ard’ complete database of CAM trials against which the
journal distribution in the CAM Field register can be
compared. However, we believe that the distribution of
journals in the CAM Field register is largely an artifact
of the way the register was developed. This is because,
in identifying citations for register inclusion, contribu-
tors often searched bibliographic databases to identify
trial citations on specific topics for their systematic re-
views rather than comprehensively searching entire
journals for all CAM trials. As a result, some journals
for which only one or two CAM trial citations were
Table 4 Number of CAM Field specialized register citations classified by type of CAM interventions
CAM intervention Citations n (% of
citations in register)
MEDLINE-indexed citations N (% of
citations in intervention category
that are MEDLINE-indexed)
Non-vitamin, non-mineral dietary supplements
(e.g., glucosamine, fish oil)
15,140 (33.8) 12,529 (82.8)
Chinese herbal medicine (e.g., Astragalus membranaceus,
Schisandra chinensis)
12,118 (27.0) 3,575 (29.5)
Diet-based therapies 9,009 (20.1) 9,009 (88.3)
Vitamin and mineral interventions (includes megavitamin
therapies and vitamin or mineral therapies for other than
medically diagnosed deficiencies or deficiency-related disorders)
7,741 (17.3) 6,468 (83.6)
Acupuncture 6,035 (13.5) 2,632 (43.6)
Relaxation (includes guided imagery and deep breathing) 3,743 (8.3) 3,194 (85.3)
Interventions using veritable energy modalities (unconventional
uses of magnets, phototherapy, electrical stimulation,
or ultrasonic therapy)
2,977 (6.6) 2,265 (76.1)
Chiropractic or osteopathic manipulation 2,606 (5.8) 2,041 (78.3)
Biofeedback 2,109 (4.7) 1,643 (77.9)
Massage 1,481 (3.3) 987 (66.6)
Traditional medicine not otherwise specified (e.g., Ayurveda, Kampo) 1,409 (3.1) 560 (39.7)
Meditation (includes mindfulness-based therapies) 1,259 (2.8) 1,056 (83.9)
Biologically based interventions not otherwise specified
(e.g., balneotherapy, prolotherapy) and excluding interventions
using energy fields
1,215 (2.8) 944 (77.7)
Interventions using putative energy fields (distant healing,
prayer, qi gong, reiki, spiritual healing, and therapeutic touch)
1,210 (2.7) 801 (66.2)
Sensory art therapies (includes art, dance, drama, music,
and play therapy)
1,136 (2.5) 911 (80.2)
Hypnosis 780 (1.7) 600 (76.9)
Homeopathy 755 (1.7) 302 (40.0)
Manipulative and body-based therapies not otherwise
specified (e.g., Alexander technique, Pilates)
438 (0.9) 212 (48.4)
Yoga 333 (0.7) 242 (72.7)
Tai chi 188 (0.4) 149 (79.3)
Chelation therapy 153 (0.3) 148 (96.7)
Unclassified 3,093 (6.9) 2,124 (68.7)
Totals* 44,840 28,850 (64.3)
*Because individual citations were frequently classified into more than one CAM intervention category, the sum of the numbers of citations classified into each
CAM intervention category exceeds the total number of citations in the CAM Field register (i.e., 44,840).
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itional trials that have not yet been identified. Continued
efforts to identify trials will likely change the distribution
of citations across journals. Such efforts may also change
the characteristics of the register in other ways (e.g., the
number and proportion of trials covering particular
CAM interventions or published in particular languages)
that are not possible to quantify in advance. While the
ultimate aim is for the CAM Field register to be a com-
prehensive source of CAM controlled trials, the register
cannot currently be considered to be comprehensive.
Therefore, systematic reviewers of CAM interventions
should search multiple electronic and other sources forrelevant CAM trials, in addition to searching the CAM
Field register.
The strength of the register in terms of its coverage of
difficult to locate trials may, however, be associated with
potential weaknesses in terms of the quality of these tri-
als. The largest subset of non-MEDLINE citations in the
register (51%) is trials published in Chinese. These
Chinese-language trials were included in the register if
the trial publication stated that a random or quasi-
random procedure was used to assign participants to
treatment groups. However, a recent telephone survey of
authors of ‘claimed’ randomized trials conducted in
China discovered that only 7% could be confirmed to
Table 5 Number of CAM Field specialized register citations classified by type of medical condition
Medical conditions Citations n (% of
citations in register)
MEDLINE-indexed citations N (% of citations
in medical condition category that are
MEDLINE-indexed)
Heart and circulation 8,028 (17.9) 5,585 (69.6)
Anesthesia and pain control 7,656 (17.1) 5,492 (71.7)
Mental health 7,472 (16.7) 5,646 (75.6)
Endocrine and metabolic 6,188 (13.8) 3,797 (61.4)
Gastroenterology 3,378 (7.5) 2,354 (69.7)
Orthopedics and trauma 3,331 (7.4) 2,263 (67.9)
Cancer 2,983 (6.7) 2,205 (73.9)
Lungs and airways 2,545 (5.7) 1,828 (71.8)
Tobacco, drugs, and alcohol dependence 2,286 (5.1) 1,935 (84.6)
Neonatal care 2,252 (5.0) 1,924 (85.4)
Rheumatology 2,199 (4.9) 1,580 (71.9)
Infectious disease 2,080 (4.6) 1,128 (54.2)
Pregnancy and childbirth 2,050 (4.6) 1,642 (80.1)
Kidney disease 1,849 (4.1) 1,207 (65.3)
Neurology 1,697 (3.8) 1,289 (76.0)
Gynecology 1,598 (3.6) 1,142 (71.5)
Skin 1,187 (2.6) 746 (62.8)
Dentistry and oral health 1,123 (2.5) 896 (79.8)
Ear, nose, and throat 1,108 (2.5) 742 (67.0)
Eyes and vision 764 (1.7) 505 (66.1)
Urology 690 (1.5) 593 (85.9)
Wounds 667 (1.5) 505 (75.7)
Developmental, psychosocial, and learning problems 656 (1.5) 567 (86.4)
Blood disorders 596 (1.3) 435 (73.0)
Genetic disorders 214 (0.5) 148 (69.2)
Unclassified 6,635 (14.8) 3,298 (49.7)
Totals* 44,840 28,850 (64.3)
*Because individual citations were frequently classified into more than one medical condition category, the sum of the numbers of citations classified into each
medical condition category exceeds the total number of citations in the CAM Field register (i.e., 44,840).
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groups [25]. Inclusion in systematic reviews of such
Chinese trials claiming to be randomized, but not con-
firmed as such by systematic reviewers, may inflate these
reviews’ meta-analytic effect estimates [26]. In addition,
a 1998 review of the outcomes of non-English language
trials by Vickers et al. found that acupuncture trials
conducted in China reported positive results 100% of
the time, and Chinese trials of other interventions
reported positive results 99% of the time, strongly
suggesting the preferential publication in China of trials
with positive results [27]. Although Chinese language
trials reflect the majority of non-English language trials
included in the register, the issue of a publication or
reporting bias favoring positive results may also be rele-
vant to other non-English trials included in the register.For example, the Vickers et al. 1998 review found
that not only acupuncture trials from China, but also
acupuncture trials from Japan, Hong Kong, and
Taiwan were uniformly positive. Also, a recent pre-
liminary investigation into the results of the Japanese
Kampo trials included in the CAM Field register
found that only a small number of Kampo trials have
negative results (Kiichiro Tsutani, personal communi-
cation, 14 March 2011), and an informal assessment
of CAM Korean trials indicated that negative results
were rare (Byeung-Cheul Shin, personal communica-
tion, 13 July 2012). The positive results of non-
English language CAM trials likely explain why
including such trials in CAM-related systematic re-
views tends to inflate meta-analysis effect estimates,
according to a 2005 empirical study [28].
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more recent Chinese-language trials may, however, be
better than that of the earlier trials because, for example,
the CONSORT statement has recently been more widely
disseminated in China [29], including in Chinese
journals of TCM [30]. In addition, while the Vickers
et al. 1998 review [27] found that Chinese acupuncture
trials published up to 1998 were uniformly positive, it is
not known whether or not more recent Chinese trials
are also likely to be uniformly positive. An important
topic area for future research is to determine whether
there is a publication bias favoring positive results in
more recent trials from China. However, while
conducting research studies to assess for the likelihood
of publication bias in Chinese trials may be informative
in determining the scope of the problem, the only way
to avoid publication bias in Chinese trials is to ensure
that all initiated Chinese language trials are known about
through the registration of Chinese trials at inception,
which is currently being implemented [31]. Universal
trial registration, in conjunction with reporting of trial
registration numbers in publications, might also serve as
a tool in addressing duplicate publication [32], which
some studies have observed to be prevalent among
Chinese, Japanese, and Korean trials [33-35]. In the in-
terim, for systematic reviews including a large number
of Chinese trials, a possible approach for assessing the
impact of a potential publication bias related to the
Chinese trials may be to mark the Chinese trials in fun-
nel plots in systematic reviews.
Despite these concerns over the validity of Chinese tri-
als in general, it seems inappropriate to exclude trials
from systematic reviews on the basis of language or
country of publication alone. A more measured ap-
proach may be to search for Chinese trials and to tele-
phone interview the authors of potentially eligible trials
to try and assess whether the trials were truly random-
ized before including them in the review. If concerns
about the validity of the trials remain, even after the
telephone interviews with the authors, a possible ap-
proach is to include in the review those trials (Chinese
or Western) for which there remains uncertainty about
whether true randomization was used, but to be more
restrictive when presenting the key findings, such as the
abstract conclusions and the summary of findings table
[36]. Another approach may be to analyze the potential
influence of risk of bias measures (e.g., adequacy of
randomization) on effect estimates using subgroup ana-
lyses or sensitivity analyses. Either way, such assessment
and analysis approaches should probably be based on
risk of bias measures rather than on the language of
country of origin of the trials. This is because generaliz-
ing about individual Chinese language trials, for ex-
ample, based on meta-research of the characteristics ofChinese trials overall would be an erroneous oversimplifi-
cation. Instead, each trial included in a systematic review
needs to be individually evaluated on its risks of bias, as-
suming either that the trial publication is sufficiently in-
formative or that the trial author can be contacted for
further information. Such risk of bias assessments can
then be incorporated into the review’s analysis.
In addition to providing a source of trials for inclusion
in systematic reviews, the register may also be used for
investigations into the optimal use of CAM research re-
sources and the prioritization of future CAM reviews.
This analysis of the types of CAM interventions and
health conditions covered in the register is a first step in
conducting such investigations. That is, the number of
citations related to various CAM interventions (e.g.,
diet-based therapies) and the number of citations related
to various medical conditions (e.g., endocrine and meta-
bolic disorders) may be used for research into whether
there is a correlation between those CAM interventions
most frequently investigated in trials and those most
commonly used, and whether the most serious or preva-
lent health conditions are proportionately represented
with the highest number of CAM trials. If trials of com-
monly used interventions and/or trials for serious or
prevalent health conditions are lacking, this may indicate
that CAM research resources should be directed to these
areas. In addition, the trial database may also be useful
for prioritizing future Cochrane reviews by identifying
CAM intervention/health condition pairings for which
there are available trials in the register but no existing
Cochrane review. The fact that the same classification cat-
egories were used for CAM intervention types and health
conditions, for both the trial citations in the specialized
register and for a separate database of CAM-related
Cochrane reviews [10], should facilitate such identifica-
tion. However identifying potential future systematic re-
views to prepare will require additional narrowing down
of some of our CAM intervention type categories (e.g.,
“Chinese herbal medicine”) and health condition categor-
ies (e.g., “mental health”) in order to identify more specific
intervention/condition pairings (e.g., the Chinese herbal
medicine formula Free and Easy Wanderer for depression)
for systematic reviews. Future plans for the CAM Field
specialized register include augmenting the size and scope
of the register through ongoing searches and international
partnerships, and developing methods to characterize
groups of trials according to intervention/condition char-
acteristics and mapping these groups to gaps in Cochrane
systematic reviews.
Conclusions
The number of citations included in the CAM Field spe-
cialized register increased nearly tenfold between 2006
and 2011 as a result of a program of extensive searching
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CAM Field register citations are not MEDLINE-indexed
and many of these non-MEDLINE-indexed citations are
published in languages other than English. While the
register provides access to thousands of difficult to
locate citations of trials, many of these trials are likely to
be of low quality and may overestimate treatment
effects. When these trials are considered for inclusion in
systematic reviews, it is extremely important that their
risk of bias is adequately assessed.
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